WO1998028261A1 - A process for the purification of an intermediate useful in the synthesis of iodinated contrast media - Google Patents

A process for the purification of an intermediate useful in the synthesis of iodinated contrast media Download PDF

Info

Publication number
WO1998028261A1
WO1998028261A1 PCT/EP1997/007077 EP9707077W WO9828261A1 WO 1998028261 A1 WO1998028261 A1 WO 1998028261A1 EP 9707077 W EP9707077 W EP 9707077W WO 9828261 A1 WO9828261 A1 WO 9828261A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
soluble
compound
purification
alcohol solvent
Prior art date
Application number
PCT/EP1997/007077
Other languages
French (fr)
Inventor
Marco Villa
Maurizio Paiocchi
Fabio Benedetti
Original Assignee
Bracco International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco International B.V. filed Critical Bracco International B.V.
Priority to AU57590/98A priority Critical patent/AU5759098A/en
Priority to EP97953838A priority patent/EP0888287A1/en
Publication of WO1998028261A1 publication Critical patent/WO1998028261A1/en
Priority to NO983872A priority patent/NO308698B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Definitions

  • the present invention relates to a process for the purification of an intermediate useful in the synthesis of iodinated contrast media, more particularly to a process for the purification of the compound -5-(2- acetoxy-propionylamino)-2,4,6-triiodo-isophthaloyl di- chloride (hereinafter referred to as compound A).
  • Compound A disclosed in British Patent n° 1,472,050 (Savac AG), is an intermediate for the synthesis of ( S )-N,N ' -bis[2-hydroxy-( 1-hydroxymethyl )- ethyl]-5-( 2-hydroxypropionylamino )-2 ,4 , 6-triiodo-iso- phthalamide, an X-ray non-ionic contrast medium, also known under the non-proprietary name iopamidol.
  • the industrial synthesis of compound A still follows the synthetic scheme disclosed in British Patent n° 1,472,050, consisting in the following steps:
  • the recovery of crude compound A according to what described in British Patent n. 1,472,050 is effected by partial evaporation of the solvent, treatment with water and ice and filtration of the crystalline precipitate which has however to be further purified by suspension in warm chloroform.
  • the warm treatment with a chlorinated, highly toxic solvent is clearly industrially unsuitable from the economic and environmental point of views.
  • the resulting compound A is particularly pure, having a high enantiomeric purity, i.e. an e. e. higher than 92%.
  • the water-soluble C 2 ⁇ C 5 alcohol solvent is selected from propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol , 2-ethoxyethanol ( cellosolve ) , 2-methoxyethanol ( ethylcellosolve ) .
  • 2-Ethoxyethanol (cellosolve) is preferably used.
  • the amount of water- soluble C,-Cr alcohol solvent generally ranges from 20% to 80% on the basis of the reaction mixture volume, preferably from 40% to 60%.
  • the dilution of the reaction mixture with a water-soluble C 3 -C 5 alcohol solvent is carried out at low temperatures, generally from 0°C to 20°C, preferably from 5°C to 10°C.
  • the resulting solution is added to a water amount 2-5 times the volume of the solution itself.
  • the addition to water is carried out at a temperature from 10°C to 20°C, preferably from 15°C to 20°C.
  • the resulting suspension is filtered to obtain pure compound A.
  • the whole purification process is extremely simple and involves no separation of the phases, i.e. it makes use of water-soluble organic solvents.
  • the solvent used in the purification process of the present invention is an alcohol solvent which could react directly with compound A thus yielding side- products.
  • compound A is obtained in a pure form.
  • this process allows to obtain compound A with a high enantio eric purity, i.e. an enantiomeric purity degree suitable for the subsequent use in the synthesis of iopamidol, to obtain iopamidol with a rotatory power fulfilling the requirements of Pharmacopoeia.
  • the process of the invention is also suitable for the purification and the recovery of compound A from reaction mixtures containing halo acids.
  • a further object of the invention is a process for the preparation of iopamidol, which process comprises the preparation of compound L-5-( 2-acetoxypropio- nylamino)-2,4, 6-triiodoisophthaloyl dichloride by reaction between L-2-acetoxypropionyl chloride and 5- amino-2,4,6-triiodo-isophthaloyl dichloride in N,N- dimethylaceta ide and the purification thereof diluting the reaction mixture with a water-soluble 3 ⁇ C 5 alcohol solvent, adding the resulting solution to a suitable amount of water and filtering.
  • the present invention is further illustrated by the following example.
  • Example L-2-acetoxypropionyl chloride (2 g; 166 mmoles) is added in 15 minutes to N,N-dimethylacetamide (23 ml), keeping the temperature at 10 - 15°C. The solution is heated to 23°C and, keeping this temperature, a solution of 5-ammmino-2 , 4 , 6-triiodoisophthaloyl dichloride (50 g; 84 mmoles) in N,N-dimethylacetamide (75 ml) is added in 6 hours. When the addition is completed, the mixture is kept under stirring for 15 hours. After this time, the starting product is lower than 1%.

Abstract

A process for the purification of the compound L-5-(2-acetoxypropionylamino)-2,4,6-triiodoisophthaloyl dichloride by treatment with a water-soluble C3-C5 alcohol solvent and water.

Description

A PROCESS FOR THE PURIFICATION OF AN INTERMEDIATE USEFUL IN THE SYNTHESIS OF lODINATED CONTRAST MEDIA
The present invention relates to a process for the purification of an intermediate useful in the synthesis of iodinated contrast media, more particularly to a process for the purification of the compound -5-(2- acetoxy-propionylamino)-2,4,6-triiodo-isophthaloyl di- chloride (hereinafter referred to as compound A).
Compound A, disclosed in British Patent n° 1,472,050 (Savac AG), is an intermediate for the synthesis of ( S )-N,N ' -bis[2-hydroxy-( 1-hydroxymethyl )- ethyl]-5-( 2-hydroxypropionylamino )-2 ,4 , 6-triiodo-iso- phthalamide, an X-ray non-ionic contrast medium, also known under the non-proprietary name iopamidol. As far as we know, the industrial synthesis of compound A still follows the synthetic scheme disclosed in British Patent n° 1,472,050, consisting in the following steps:
1. preparation of 5-amino-2 , 4, 6-triiodo-isophthalic acid by iodination of 5-amino-isophthalic acid;
2. preparation of 5-amino-2 , 4 , 6-triiodo-isophthaloyl dichloride; 3. reaction of 5-amino-2 , 4 , 6-triiodo-isophthaloyl dichloride with L-2-acetoxy-propionyl chloride to obtain L-5-( 2-acetoxy-pro ionylamino )-2 , 4 , 6-triio- doisophthaloyl dichloride (compound A). The reaction of step 3 has been described in example lb of the above cited British Patent. Such reaction is performed adding L-2-acetoxy-propionyl chloride to a solution of 5-amino-2 , 4 , 6-triiodo- isophthaloyl dichloride in N, N-dimethylacetamide at 3- 5°C. Improvements of the process described above have recently been reported in literature, which comprise the addition of catalytic amounts of acids to the reaction mixture. In particular, the addition of catalytic amounts of Lewis acids has been described in British
Patent application n° 2,271,990 in the Applicant's name, while the addition of catalytic amounts of halo acids has been described in International Patent application n. WO 96/37460 in the name of Fructamine S.p.a. The recovery of crude compound A according to what described in British Patent n. 1,472,050 is effected by partial evaporation of the solvent, treatment with water and ice and filtration of the crystalline precipitate which has however to be further purified by suspension in warm chloroform. The warm treatment with a chlorinated, highly toxic solvent is clearly industrially unsuitable from the economic and environmental point of views. In British Patent application n° 2,271,990 and in International Patent application n° WO 96/37460, the recovery and purification of compound A are carried out by dilution of the reaction mixture with an organic solvent and water, separation of the phases and evaporation of the solvent or precipitation of compound A with water. Now it has been found that the separation of the phases in the purification of compound A can be avoided by diluting with a water-soluble alcoholic C3-C5 solvent the reaction mixture containing crude compound A in N,N- dimethylaceta ide, then pouring the resulting solution into water. Pure compound A precipitates directly and can be separated by a simple filtration. Therefore it is an object of the present invention a process for the purification of compound L-5-(2- acetoxypropionylamino ) -2 , 4 , 6-triiodo-isophthaloyl dichloride obtained by reaction between L-2- acetoxypropionyl chloride and 5-amino-2 ,4 , 6- triiodoisophthaloyl dichloride in N,N-dimethylacetamide , which process comprises diluting the reaction mixture with a water-soluble C3-C5 alcohol solvent, adding the resulting solution to a suitable amount of water and recovering compound L-5-( 2-acetoxypropionylamino )-2 , 4 , 6- triiodoisophthaloyl dichloride by filtration. The resulting compound A is particularly pure, having a high enantiomeric purity, i.e. an e. e. higher than 92%. The water-soluble C2~C5 alcohol solvent is selected from propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol , 2-ethoxyethanol ( cellosolve ) , 2-methoxyethanol ( ethylcellosolve ) . 2-Ethoxyethanol (cellosolve) is preferably used. The amount of water- soluble C,-Cr alcohol solvent generally ranges from 20% to 80% on the basis of the reaction mixture volume, preferably from 40% to 60%. The dilution of the reaction mixture with a water-soluble C3-C5 alcohol solvent is carried out at low temperatures, generally from 0°C to 20°C, preferably from 5°C to 10°C. After dilution with the water-soluble C3-C5 alcohol solvent, the resulting solution is added to a water amount 2-5 times the volume of the solution itself. The addition to water is carried out at a temperature from 10°C to 20°C, preferably from 15°C to 20°C. The resulting suspension is filtered to obtain pure compound A. The whole purification process is extremely simple and involves no separation of the phases, i.e. it makes use of water-soluble organic solvents. This is surprising and advantageous compared with the known technique and it is per se surprising in that the solvent used in the purification process of the present invention is an alcohol solvent which could react directly with compound A thus yielding side- products. On the contrary, with the process of the invention, compound A is obtained in a pure form. Moreover, this process allows to obtain compound A with a high enantio eric purity, i.e. an enantiomeric purity degree suitable for the subsequent use in the synthesis of iopamidol, to obtain iopamidol with a rotatory power fulfilling the requirements of Pharmacopoeia. The process of the invention is also suitable for the purification and the recovery of compound A from reaction mixtures containing halo acids.
A further object of the invention is a process for the preparation of iopamidol, which process comprises the preparation of compound L-5-( 2-acetoxypropio- nylamino)-2,4, 6-triiodoisophthaloyl dichloride by reaction between L-2-acetoxypropionyl chloride and 5- amino-2,4,6-triiodo-isophthaloyl dichloride in N,N- dimethylaceta ide and the purification thereof diluting the reaction mixture with a water-soluble 3~C5 alcohol solvent, adding the resulting solution to a suitable amount of water and filtering.
The present invention is further illustrated by the following example.
Example L-2-acetoxypropionyl chloride (2 g; 166 mmoles) is added in 15 minutes to N,N-dimethylacetamide (23 ml), keeping the temperature at 10 - 15°C. The solution is heated to 23°C and, keeping this temperature, a solution of 5-ammmino-2 , 4 , 6-triiodoisophthaloyl dichloride (50 g; 84 mmoles) in N,N-dimethylacetamide (75 ml) is added in 6 hours. When the addition is completed, the mixture is kept under stirring for 15 hours. After this time, the starting product is lower than 1%. The mixture is accurately cooled to 5°C and added with cellosolve (50 ml) in 30 minutes, keeping the temperature below 20°C. The solution is dropped into water (400 ml) under stirring, keeping temperature at 15 - 20°C, then it is stirred for 1 hour and the precipitate is filtered, washed with water (100 ml) and dried at 60°C under vacuum until constant weight, thereby obtaining 57 g of compound A. 93% HPLC titre, 89% yield, 93.6% e. e..

Claims

1. A process for the purification of compound L-5-(2- acetoxypropionylamino ) -2 , 4 , 6-triiodo-isophthaloyl dichloride by reaction between L-2-acetoxypropionyl chloride and 5-amino-2 ,4, 6-triiodoisophthaloyl dichloride in N,N-dimethylacetamide , which process comprises diluting the reaction mixture with a water-soluble 3~C5 alcohol solvent, adding the resulting solution to a suitable amount of water and recovering compound L-5-(2- acetoxypropionylamino ) -2 , 4 , 6-triiodoisophthaloyl dichloride by filtration.
2. A process according to claim 1 wherein the water- soluble C -C alcohol solvent is selected from propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert- butanol, 2-ethoxyethanol , 2-methoxyethanol .
3. A process according to claim 2 in which the water- soluble C -Cc alcohol solvent is 2-ethoxyethanol .
4. A process according to claim 1 wherein the amount of water-soluble C3-C5 alcohol solvent ranges from 20% to 80% on the basis of the reaction mixture volume.
5. A process according to claim 1 wherein the amount of water-soluble C3-C5 alcohol solvent ranges from 40% to 60% on the basis of the reaction mixture volume.
6. A process for the preparation of iopamidol, which process comprises the preparation of compound L-5-(2- acetoxypropionylamino)-2 , 4, 6-triiodoisophthaloyl dichloride by reaction between L-2-acetoxypropionyl chloride and 5-amino-2 , 4 , 6-triiodo-isophthaloyl dichloride in N,N-dimethylacetamide and the purification thereof diluting the reaction mixture with a water-soluble C -Cr alcohol solvent, adding the resulting solution to a suitable amount of water and filtering,
PCT/EP1997/007077 1996-12-24 1997-12-17 A process for the purification of an intermediate useful in the synthesis of iodinated contrast media WO1998028261A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU57590/98A AU5759098A (en) 1996-12-24 1997-12-17 A process for the purification of an intermediate useful in the synthesis of iodinated contrast media
EP97953838A EP0888287A1 (en) 1996-12-24 1997-12-17 A process for the purification of an intermediate useful in the synthesis of iodinated contrast media
NO983872A NO308698B1 (en) 1996-12-24 1998-08-21 A method of purifying an intermediate useful in the synthesis of iodinated contrast agents, as well as a method of preparing Iopamidol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002737A IT1289521B1 (en) 1996-12-24 1996-12-24 INTERMEDIATE PURIFICATION PROCESS
ITMI96A002737 1996-12-24

Publications (1)

Publication Number Publication Date
WO1998028261A1 true WO1998028261A1 (en) 1998-07-02

Family

ID=11375488

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/007077 WO1998028261A1 (en) 1996-12-24 1997-12-17 A process for the purification of an intermediate useful in the synthesis of iodinated contrast media

Country Status (7)

Country Link
EP (1) EP0888287A1 (en)
AU (1) AU5759098A (en)
IN (1) IN184019B (en)
IT (1) IT1289521B1 (en)
NO (1) NO308698B1 (en)
WO (1) WO1998028261A1 (en)
ZA (1) ZA9711505B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472050A (en) * 1974-12-13 1977-04-27 Savac Ag Non-ionic x-ray contrast agents
GB2271990A (en) * 1992-10-27 1994-05-04 Zambon Spa Process for the preparation of L-5-(2-acetoxy-propionyl-amino)-2,4,6-triiodo- isophthalic acid dichloride
WO1996037460A1 (en) * 1995-05-23 1996-11-28 Fructamine S.P.A. Process for the preparation of a dicarboxylic acid dichloride

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472050A (en) * 1974-12-13 1977-04-27 Savac Ag Non-ionic x-ray contrast agents
GB2271990A (en) * 1992-10-27 1994-05-04 Zambon Spa Process for the preparation of L-5-(2-acetoxy-propionyl-amino)-2,4,6-triiodo- isophthalic acid dichloride
WO1996037460A1 (en) * 1995-05-23 1996-11-28 Fructamine S.P.A. Process for the preparation of a dicarboxylic acid dichloride

Also Published As

Publication number Publication date
EP0888287A1 (en) 1999-01-07
AU5759098A (en) 1998-07-17
IT1289521B1 (en) 1998-10-15
ZA9711505B (en) 1998-06-25
NO308698B1 (en) 2000-10-16
NO983872D0 (en) 1998-08-21
ITMI962737A1 (en) 1998-06-24
NO983872L (en) 1998-10-22
IN184019B (en) 2000-06-03

Similar Documents

Publication Publication Date Title
US6974882B2 (en) Preparation of iodixanol
USRE36433E (en) Process for the purifying of iopamidol
CA2389379C (en) Method for the preparation of 5-carboxyphthalide
AU2005257478B2 (en) Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride
US20090326266A1 (en) Process for the preparation of gabapentin
WO1998028261A1 (en) A process for the purification of an intermediate useful in the synthesis of iodinated contrast media
EP1758867B1 (en) Process for preparing oxcarbazepine
CA2201012C (en) Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media
EP0900196A1 (en) A process for the preparation of an intermediate useful in the synthesis of iodinated contrast media
US20050119351A1 (en) Polymorphic forms of sertraline hydrochloride
US5091540A (en) Process for preparing clotrimazole
US4925642A (en) Process for the preparation and the isolation of aromatic nitriles
JP2000505064A (en) Racemization of amines
JP4408634B2 (en) Method for separating isomers of nitroisoquinoline
US6008413A (en) Process for recrystallizing 1,3-bis(aminophenoxy benzene)
EP0901461B1 (en) A process for the preparation of an intermediate useful in the synthesis of iodinated contrast media
CN115197099A (en) Preparation method of N-Boc-1,4-phenylenediamine
JP2001510178A (en) Method for producing 3-hydroxy-2-methylbenzoic acid
JPH11335351A (en) Purification of n-carbobenzoxy-s-phenylcysteine
JP2000128826A (en) Purification of m-halogenobenzoic acid compounds
CA2448300A1 (en) Process for preparing sertraline intermediates
JPH05140120A (en) New production of 2-hydroxyquinoxaline
JP2001199969A (en) Method for producing quinazoline compound and method for purifying the same
JPH05125094A (en) Production of alpha-l-aspartyl-l-phenylalanine methyl ester

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE

WWE Wipo information: entry into national phase

Ref document number: 09125589

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1997953838

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997953838

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1997953838

Country of ref document: EP